IP Library Granted Patent US 9,057,065
Granted Patent B2
US 9,057,065 · App. 14/021,260 · Granted Jun 16, 2015

Small RNA-dependent translational regulatory system in cell or artificial cell model

Inventors: Tan Inoue (Kyoto, JP); Hirohide Saito (Kyoto, JP); Yusho Kato (Hyogo, JP); Kenichi Yoshikawa (Kyoto, JP); Ayako Yamada (Paris, FR); Toru Yamanaka (Hyogo, JP)
Assignee: JAPAN SCIENCE AND TECHNOLOGY AGENCY
C12N15/11C12N15/111C12N15/67C12N2310/141C12N2320/00C12N2330/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,057,065
App. No.
14/021,260
Granted
Jun 16, 2015
Kind
B2
Abstract

An object of the present invention is to construct an mRNA which specifically responds to a short RNA sequence and can activate, repress, and regulate the translation of the desired gene, and to construct an artificial cell model system using a liposome comprising the mRNA and a cell-free translational system encapsulated therein. The present invention provides: an mRNA comprising a target RNA-binding site located immediately 5′ to the ribosome-binding site, and a nucleotide sequence located 5′ to the target RNA-binding site, the nucleotide sequence being complementary to the ribosome-binding site; an mRNA comprising a small RNA-binding site located 3′ to the start codon, and a nucleotide sequence located 3′ to the small RNA-binding site, the nucleotide sequence encoding a protein; and a liposome comprising any of these mRNAs encapsulated therein.

Claims (7)

1. An mRNA comprising a microRNA-binding site located 3′ to the start codon and a nucleotide sequence located 3′ to the microRNA-binding site, the nucleotide sequence encoding a protein, wherein the microRNA-binding site has a sequence complementary to a microRNA selected from the group consisting of miR164, miR170, miR171, miR156 miR159a and miR163.

2. A translation/expression regulation system comprising an mRNA according to claim 1 .

3. A liposome comprising an mRNA according to claim 1 encapsulated therein.

4. The liposome according to claim 3 , wherein the liposome is produced by the method comprising steps of:

mixing one or more phospholipids, the mRNA, a cell-free translational system, and an aqueous solution into an oily liquid to form a W/O emulsion in which the mRNA and the cell-free translational system are encapsulated in the phospholipid vesicle;

adding an oily liquid containing outer membrane lipids dissolved therein, to an aqueous phase to form a molecular membrane in which the lipids are arranged at the oil/water interface; and

adding the W/O emulsion to the oil phase side of the interface and moving the W/O emulsion to the aqueous phase side of the interface such that the outer membrane lipid is added outside of the W/O emulsion to form a liposome.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2013
From: INOUE, TAN; SAITO, HIROHIDE; KATO, YUSHO; YOSHIKAWA, KENICHI; YAMADA, AYAKO; YAMANAKA, TORU
To: JAPAN SCIENCE AND TECHNOLOGY AGENCY
Reel/Frame 031174/0789 →
Priority Claims (1)
JP 2007-303661 · Nov 22, 2007 · national
Continuity (2)
Division 12743908
Related Publication 20140030707A1 · Jan 30, 2014